We serve Chemical Name:Glutaronitrile CAS:544-13-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Glutaronitrile
CAS.NO:544-13-8
Synonyms:1,3-DICYANOPROPANE;Glutarodinitrile;Pentanedinitrlie;Pentanedinitrile;Glutaric dinitrile;3-thiaglutaronitrile;EINECS 208-861-6;glutaric acid dinitrile;Glutaronitrile;Glutarsaeuredinitril;TRIMETHYLENE CYANIDE;Glutaronitrle;1,3-Dicyanopopane.;MFCD00001970
Molecular Formula:C5H6N2
Molecular Weight:94.115
HS Code:2926909090
Physical and Chemical Properties:
Melting point:−29 °C(lit.)
Boiling point:287.3±13.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.425
PSA:47.58000
Exact Mass:94.053101
LogP:-0.72
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2810 6.1/PG 3
Packing Group:III
Contact us for information like 1,3-DICYANOPROPANE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00001970 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00001970 Use and application,Glutaric dinitrile technical grade,usp/ep/jp grade.
Related News: The role of a trusted contract development and manufacturing organization (CDMO), with long-standing record of regulatory compliance and efficient project management, can help tremendously in reduced time and costs for the early phase development and commercialization of small molecule active pharmaceutical ingredients (APIs) in the pharmaceutical industry, according to experts. Ni2tetrakis(monothiobebzoato-S)(C2H5OH) manufacturers Although Elliot said it wasn’t advocating a specific outcome but for a “robust” and “credible” selection process, it did say that the CEOs of the two companies “must have the skillsets and expertise to match their respective tasks at hand.” Disilane, 1,2-bis(4-ethenylphenyl)-1,1,2,2-tetramethyl- suppliers It’s official. Nearly two years after the FDA granted conditional approval to Merck’s Keytruda and Eisai’s Lenvima for endometrial cancer, the U.S. regulator has blessed the combination therapy, with no strings attached. 2-amino-N-((1S)-2-(benzyloxy)-1-(1-(4-(3-hydroxypiperidin-1-yl)-4-oxobutyl)-1H-tetrazol-5-yl)ethyl)-2-methylpropanamide vendor & factory.
